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and George Falkay, Ph.D., D.Sc.a
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Objective: To focus on the possible roles of a1-adrenergic receptors (a1-ARs) in rat embryonic implantation.
Design: Laboratory study.
Setting: Animal and pharmacology laboratory at Department of Pharmacodynamics and Biopharmacy, University
of Szeged, Hungary.
Animal(s): Pregnant and nonpregnant Sprague-Dawley rats.
Intervention(s): Uterus tissues were collected during the peri-implantation period.
Main Outcome Measure(s): We used a reverse transcription–polymerase chain reaction (RT-PCR) and Western
blotting to demonstrate the expressions of mRNAs and the protein expressions of the a1-AR subtypes in the
early-pregnant uterus. Electric field stimulation was applied to test the pharmacologic reactivity of the a1A-AR,
and the physiologic role of this receptor was tested in a knock-down transformed animal model using an antisense
oligonucleotide that elicits sequence-selective inhibition of the a1A-AR gene expression.
Result(s): The presence of all a1-AR subtypes (a1A, a1B, and a1D) was proved, with a predominance of a1A-AR.
The maximal expression of the a1A-AR was attained on the day of implantation. The selective a1A antagonist
5-methylurapidil inhibited the contraction in a dose-dependent manner. The number of implantation sites was
decreased (75%) in the a1A-AR knock-down transformed rats.
Conclusion(s): We assume that the a1A-AR predominance plays a crucial role in embryonic implantation in the rat.
(Fertil Steril 2009;91:1224–9. 2009 by American Society for Reproductive Medicine.)
Key Words: a1-adrenergic receptors, rat, implantation, antisense oligonucleotideAdrenergic signal transduction is involved in many aspect of
pregnancy. The b-adrenergic receptors (b-ARs) are involved
in uterine relaxation, which is reflected in clinical practice by
frequent application of b2-agonist as tocolytic agents. Stimu-
lation of a1-ARs results in vasoconstriction and uterine con-
traction; stimulation of a2-ARs results in inhibition of
norepinephrine release and it may also contribute to uterine
contraction. Smooth muscle tone depends, at least in part,
on the relative activity of the AR system, and abnormal func-
tioning of these receptors may be involved in preterm labor
and the pathophysiologic mechanisms of preeclampsia or
gestational hypertension (1).
Our earlier experiments revealed a predominance of the
a1-ARs at the end of pregnancy and postpartum (2–4) and
the density and pharmacologic reactivity indicated that
a1A-AR seems to play the major role in the late-pregnant
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a1-ARs in implantation.
Implantation is a complex process in which the embryo
makes close contact with the maternal endometrium during
the establishment of pregnancy. Successful implantation re-
quires precise coordination between the embryo and the
uterus under the influence of ovarial steroids. Generalized
uterine swelling and progressive closure of the uterine lumen
position the blastocyst immediately adjacent to the luminal
epithelium, with eventual attachment of the embryo to the
uterus on day 5 of pregnancy in the rat (6).
The aim of this study was to determine the changes in ex-
pression of the a1-AR messenger RNA (mRNA) subtypes
near the implantation period in the rat. To demonstrate the
expressions of the a1-AR subtypes, mRNAs, and proteins,
we used a reverse transcription–polymerase chain reaction
(RT-PCR) and Western blotting. Electric field stimulation
was applied to test the a1-AR functions through the uterine
contractions at the time of implantation. Finally, an a1A-AR
knock-down transformed animal model was set up with an
antisense oligodeoxynucleotide (AON) to prove the crucial
role of the a1A-AR subtype in blastocyte implantation.0015-0282/09/$36.00
, Published by Elsevier Inc. doi:10.1016/j.fertnstert.2008.01.081
eged from ClinicalKey.com by Elsevier on July 17, 2019.
n. Copyright ©2019. Elsevier Inc. All rights reserved.
MATERIALS AND METHODS
Housing and Handling of the Animals
The animals were treated in accordance with the European
Communities Council Directives (86/609/ECC) and the Hun-
garian Act for the Protection of Animals in Research
(XXVIII.tv.32.x). All experiments involving animal subjects
were carried out with the approval of the Hungarian Ethical
Committee for Animal Research (registration number IV/
1813-1/2002). Sprague-Dawley rats (Charles-River Labora-
tories, Budapest, Hungary) were kept at 22  3C; the rela-
tive humidity was 30%–70% and the light/dark cycle was
12/12 hours. They were maintained on a standard rodent pel-
let diet (Charles-River Laboratories) with tap water available
ad libitum. The animals were sacrificed by CO2 inhalation.
Mating of the Animals
Mature female (180–200 g) and male (240–260 g) Sprague-
Dawley rats were mated in a special mating cage. A metal
door, which was movable by a small electric engine, sepa-
rated the rooms for the male and female animals. A timer
controlled the function of the engine. Because rats are usually
active at night, the separating door was opened before dawn.
Within 4–5 hours after the possibility of mating, vaginal
smears were taken from the female rats, and a sperm search
was performed under a microscope at a magnification of
1,200. If the search proved positive, or when smear taking
was impossible because of an existing vaginal sperm plug,
the female rats were separated and were regarded as first-
day pregnant animals.
RT-PCR Studies
Tissue isolation Female Sprague-Dawley rats (250–300 g)
were anesthetized with sodium pentobarbital (1 g/kg intra-
peritoneally [IP]). Uterus tissues from nonpregnant and preg-
nant animals were rapidly removed and dissected in ice-cold
saline (0.9% NaCl) containing 2 units/mL of recombinant
ribonuclease inhibitor (RNasin; Promega, London, United
Kingdom). The tissues were frozen in liquid nitrogen and
then stored at 70C until the extraction of total RNA.
Total RNA preparation Total cellular RNAwas isolated by ex-
traction with acid guanidinium thiocyanate-phenol-chloroform
according to the procedure of Chomczynski and Sacchi (7).
After precipitation with isopropanol, the RNA was treated
with RNase-free DNase I for 30 minutes at 37C, re-extracted
with phenol, precipitated with ethanol, washed with 75% eth-
anol, and then resuspended in diethyl pyrocarbonate-treated
water, and the RNA concentration was determined by optical
density measurement at 260 nm.
RT-PCR The RNA (0.5 mg) was denatured at 70C for
5 minutes in a reaction mixture containing 20 units of RNase
inhibitor (Invitrogen, Budapest, Hungary), 200 mM dNTP
(Sigma-Aldrich, Budapest, Hungary), 20 mM oligo(dT) (Invi-
trogen) in 50 mM Tris-HCl at pH 8.3, 75 mM KCl, and 5 mM
MgCl2 in a final reaction volume of 19 mL. After the mixture
had cooled to 4C, 20 units of M-MLV Reverse Transcriptase,Fertility and Sterility
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incubated at 37C for 60 minutes and then at 72C for
10 minutes.
The PCR assay was carried out with 5 mL of complemen-
tary DNA (cDNA), 25 mL of ReadyMix REDTaq PCR reac-
tion mix (Sigma-Aldrich), and 50 pmol sense and antisense
primers. The sequences of the primers were as reported by
Scofield et al. (8).
The PCR assay was performed with PCR Sprint thermal
cycler (Hybaid Corp., London, United Kingdom) with the fol-
lowing cycle parameters: after initial denaturation at 95C
for 3 minutes, the reactions were taken through 35 cycles of
1 minute at 94C, 1 minute of annealing at 54C (a1B-AR
and a1D-AR) or 50
C (a1A-AR) and 72C for 2 minutes. After
the last cycle, incubation was continued for 10 minutes at
72C, followed by lowering of the temperature to 4C. Simul-
taneously, we performed RT-PCR for housekeeping gene
GAPDH (9) in the uterus as a positive, internal control.
The RT-PCR products were separated on 2% agarose gels,
stained with ethidium bromide, and photographed under a UV
transilluminator. Semiquantitative analysis was performed by
densitometric scanning of the gel with KODAK EDAS290
(Csertex Ltd., Budapest, Hungary). For statistical evaluations,
data were analyzed by analysis of variance (ANOVA) with
the Neuman-Keuls test.
Western blot analysis
Protein per well (20 mg) was subjected to electrophoresis
on 10% sodium dodecyl sulfate (SDS)–polyacrylamide gels
in Series Standard Dual Cooled Units (BioRad, Budapest
Hungary). Proteins were transferred from gels to nitrocellulose
membranes (Scheicher and Schuell, Dassel, Germany), using
a semidry blotting technique (BioRad). The membranes were
blocked with 5% nonfat dry milk in Tris saline buffer (50 mM
Tris, pH 7.4, 200 mM NaCl) containing 0.1% Tween, over-
night at 4C. After washing, the blots were incubated for
1 hour at room temperature on a shaker, with a1A-AR, a1B-
AR, and a1D-AR and b-actin polyclonal antibody (1:200;
Santa Cruz Biotechnology, Santa Cruz, CA) in the blocking
buffer. The antibody binding was detected with a Western-
Breeze Chromogenic Western blot immundetection kit (Invi-
trogen). Digital images were captured with the EDAS290
imaging system (KODAK, Invitrogen), and the optical density
of each immunoreactive band was determined with Kodak
1D Images analysis software. Optical densities were calcu-
lated as arbitrary units after local area background subtraction,
normalized to the density of the b-actin immunoreactivity, and
reported as fold induction relative to the control.
Uterus Preparation and Electric Field Stimulation
Uteri were removed from rats (200–250 g) on days 4, 5, 6, or
7 of pregnancy. Muscle rings 0.5 cm long were sliced from
the uterine horns and mounted vertically between two plati-
num electrodes in an organ bath containing 10 mL of de
Jongh solution (137 mM NaCl, 3 mM KCl, 1 mM CaCl2, 1
mM MgCl2, 12 mM NaHCO3, 4 mM NaH2PO4, 6 mM1225
zeged from ClinicalKey.com by Elsevier on July 17, 2019.
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glucose, pH 7.4). The organ bath was maintained at 37C, and
carbogen (95% O2 þ 5% CO2) was bubbled through it. After
mounting, the rings were equilibrated for about 1 hour before
experiments were undertaken, with a solution change every
15 minutes. The initial tension was set to about 1.25 g, which
was relaxed to about 0.5 g at the end of equilibration. Maxi-
mal rhythmic contractions were elicited with a digital, pro-
grammable stimulator (ST-02; Experimetria U.K. Ltd.,
London, United Kingdom), as described earlier (2). Briefly,
different values of pulse width (the duration of the electric
field as a single stimulus) and period time (the time interval
between two stimuli) were used at 40 V for 240 seconds,
The shortest interval time was sought with which to elicit
rhythmic contractions. After identification of this value, the
pulse width was gradually increased as much as possible at
the constant time interval to maintain the rhythmic contrac-
tions. The stimulation parameters are shown in Table 1. The
tension of the myometrial rings was measured with a gauge
transducer (SG-02; Experimetria U.K. Ltd.) and recorded
with an ISOSYS Data Acquisition System (Experimetria
U.K. Ltd.). Noncumulative concentration–response curves to
the a1A-antagonist/inverse agonist 5-methylurapidil (5-MU)
(Sigma-Aldrich) were constructed in each experiment. After
the addition of a concentration of 5-MU, recording was per-
formed for 240 seconds. After this period, the electric field
was switched off and the tissues were washed three times
and left to rest for 5 minutes. Concentration–response curves
were fitted and areas under curves (AUCs) were evaluated and
analyzed statistically with the Prism 4.0 (GraphPad Software,
San Diego, CA) computer program. From the AUC values, the
EC50 and Emax values were calculated (EC50¼ concentration
of terbutaline eliciting 50% of the maximal [100%] inhibi-
tion of uterine contractions; Emax ¼ maximal inhibitory
effect of terbutaline on a given day of pregnancy.) For statis-
tical evaluations, data were analyzed by the Neuman-Keuls
ANOVA test.
Treatment of Animals With Antisense
Oligodeoxynucleotides
The a1A-AON (Invitrogen) was mixed with N-[1-(2,3-
dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsul-
fate (DOTAP; Boehringer-Mannheim, Mannheim, Germany)1226 Ducza et al. The a1-ARs and the implantation
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was maintained in liquid form at 4C before injection. The
effective sequence and dose–response analysis of a1A-AON
were reported earlier (10). Pregnant animals (n ¼ 12) on
day 4 under sodium pentobarbital anesthesia were treated
with a1A-AON (50 nmol/200 mL). The animals in the posi-
tive control group (n ¼ 8) were treated only with the vehicle
mixture and the negative control group (n ¼ 8) received no
injection. An incision was made in the lower abdomen and
the AON solution was injected from prechilled syringes
into the luminal space of each uterine horn. The AON sample
was administered in two steps at two locations along the
length of the horn. The incision was then closed, and the
animals were returned to their cages. Uteri were used for
further investigation on day 10 of pregnancy.
RESULTS
To determine the distribution of the a1-AR subtype mRNAs
in the pregnant rat uterus, total RNAs from each tissue
were reverse transcribed. The resulting complementary
DNAs (cDNA) were amplified by PCR using a set of primers
specific for each a1-AR cDNA sequence. The successful
normalization of RNA amounts during the RT step was ver-
ified by amplification of a fragment of the reference stan-
dard GAPDH cDNA in all of the samples analyzed. The
presence of the mRNA of all a1-AR subtypes (a1A, a1B,
and a1D) was proved and a predominance of a1A-AR
mRNA was detected (Fig. 1A). The maximal expression
of a1A-AR mRNA was attained on the day of implantation
(day 5). Lower expressions of a1B-AR and a1D-AR mRNAs
were demonstrated in the rat uterus. We did not observe any
regularity between the expressions of a1B-AR and a1D-AR
mRNAs.
The results of the Western blot analysis correlated with
those of the RT-PCR analysis. The expression of the a1A-
AR protein was the highest on days 5–6 of pregnancy
(Fig. 1B).
The selective a1A-antagonist 5-MU inhibited the electric
field stimulation -contraction in a dose-dependent manner.
The EC50 value of the compound was shifted to the left on
day 6 and to the right on day 7. The maximal inhibitory effectTABLE 1
The pulse widths and period times for in vitro electric field stimulation eliciting maximal rhythmic
contractions in early-pregnant rat uterine rings (n[ 8).
Days of pregnancy
EFS parameters 4 5 6 7
PW (ms) 75.2  2.5 78.6  9.4 80.5  10.3 70.3  20.5
PER (s) 20.3  3.4 15.0  2.9 18.2  2.7 20.0  8.5
Note: EFS ¼ electric field stimulation; PW ¼ pulse width [ms  SEM]; PER ¼ period time [s  SEM].
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of 5-MU was increased on day 5 and remained unchanged up
to day 7 (Fig. 2).
The role of the a1A-AR in implantation was investigated
with a1A-AON. We detected a decreased expression of
a1A-AR mRNA (Fig. 3), and the number of implantations
also decreased after a1A-AON treatment (75%) com-
pared to the vehicle-treated and untreated control animals
(Fig. 4).
FIGURE 1
The changes in messenger RNA (mRNA) expression
(A) and the protein level (B) of a1A-AR in the
nonpregnant and the early-pregnant rat uterus,
measured by reverse transcription–polymerase
chain reaction (RT-PCR) and Western blot, as
described in the Materials and Methods section. (not
significant ¼ P>.05; *P< .05; ***P< .001 compared
with the data on the previous day). Each bar
represents the mean  SD, n ¼ 6.
Ducza. The a1-ARs and the implantation. Fertil Steril 2009.Fertility and Sterility
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A crucial stage in pregnancy is the implantation of the em-
bryo into the endometrium. In the rat, this event occurs at
the end of day 5 of pregnancy and is regulated by several en-
dogenous factors (e.g., steroid hormones, cytokines, and
growth factors) (11). However, the tissue distribution and
the role of the adrenergic receptors in the pregnant rat uterus
in this period are unknown.
The present study is the first to illustrate the alteration in
expression of the mRNAs, of the a1-AR subtypes, and the
physiologic functions in the early-pregnant rat uterus, espe-
cially during the time of embryonic implantation.
All the a1-AR subtypes (a1A, a1B, and a1D with their
mRNAs and proteins) were found in the early-pregnant rat
uterus, with a predominance of a1A-AR. The presence of
the other two subtypes was very limited. The expression of
the a1A-AR protein was significantly increased on days 5
and 6, suggesting a special role for this receptor subtype on
these days. Because this is the period of implantation in the
rat, we presumed that this sharp increase in the receptor num-
ber may play a role in the control of the implantation process.
Our studies were focused only on the role of the a1A-AR in
the early-pregnant rat uterus.
Then we determined the function of these receptors, and
therefore investigated their roles in the control of uterine
smooth muscle contractility. Electric field-stimulated uterine
FIGURE 2
Inhibitory effects of the a1A-antagonist 5-
methylurapidil (5-MU) on electric field-stimulated
contractions on different days of early pregnancy in
the isolated rat uterus in vitro. The EC50
(concentration of terbutaline eliciting 50% of the
maximal [100%] inhibition of uterine contractions)
values were significantly shifted on days 5 and 6; the
maximal inhibitory effect was increased on day 5,
and remained unchanged up to day 7.
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contractions were inhibited by the a1A-AR inverse agonist
5-MU (12). The EC50 values indicated that the ligand–
receptor interaction is strongest on day 6 (the lowest EC50
value), whereas the maximal inhibitory effect was reached
on day 5 and remained high up to day 7. Accordingly, at
near implantation not only the number but also the sen-
sitivity and function of the a1A-AR are moderately ele-
vated, which justifies the assumption that these receptors
may play an important role in the control of this period of
pregnancy.
The contractility study was important in proving the exis-
tence of a functioning a1A-AR, but gave no direct informa-
tion about its role in implantation. Therefore, an a1A-AR
knock-down transformed animal model was developed, using
AONs. The major advantage of the antisense effect (i.e., the
selective inhibition of gene expression by antisense RNA,
DNA, or oligonucleotides) instead of a conventional drug
effect is that binding of the oligonucleotide drug to its recep-
tor (mRNA) occurs through a highly predictable and well-
characterized set of rules (Watson-Crick base pairing) (13).
Antisense inhibition, although highly specific, does not result
FIGURE 3
The changes in a1A-AR messenger RNA (mRNA)
expression after a1A-AR antisense
oligodeoxynucleotide treatment in the rat
myometrium, measured by reverse transcription–
polymerase chain reaction as described in the
Materials and Methods section. The relative
amounts of the receptor subtype mRNAs are
indicated by the optical densities of the bands (not
significant ¼ P>.05; *P< .05 compared with the data
on the previous day). Each bar represents the mean
 SD, n ¼ 6.
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a partial decrease of the expression of the a1A-AR, which im-
pedes the embryonic implantation. Treatment with DOTAP
(vehicle) was ineffective; the obtained result being purely
the consequence of the AON effect. The significant decrease
in the number of implanted embryos in the AON-treated uteri
suggests ‘‘negative’’ pharmacologic evidence of the role of
the a1A-AR in the implantation process. This means that,
with the lack of a1A-AR, a determining mechanism is
blocked, probably causing a poor adherence of the embryos
to the endometrium.
The a1A-AR expression is significantly higher on day 5 of
pregnancy. In earlier studies we proved that the number of es-
trogen receptors (ERs) (a) was elevated at the time of
implantation (day 5 of pregnancy) in the rat (14). From the
strong correlation, it was hypothesized that both receptors
should be involved in the control of implantation. The ele-
vated level of ERa mRNA on day 5 may be related to the
blastocyst implantation, because estrogen (E) is essential in
the induction of implantation. It may be assumed that E
induces epithelial proliferation in the endometrium through
FIGURE 4
The effect of a1A-AR antisense oligodeoxynucleotide
(AON) on implantation in rats (A). The absence of
implantation sites (arrows) (B) in the AON-treated rat
uteri and the presence in the control uteri (C) were
seen on day 10.
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the ERa, which is necessary for blastocyst attachment by the
end of day 5. These findings are in accord with those of a pre-
vious investigation, which demonstrated that implantation
was not observed in ER knock-out mice (15). Our theory
was based on earlier experimental results of a heterologous
regulation between E and adrenergic systems (16). In addi-
tion, we proved a strong correlation between the ERa and
a1B-AR mRNA expressions, in the pregnant human uterus,
whereas other investigators found E cross-talk to the a1B-
AR in HEK-293-transfected cells (17, 18).
In the light of our findings, we presume that a1A-AR has
a crucial role in embryonic implantation in the rat, whereas
the other two a1-AR subtypes are not involved in this process.
We assume that this role of the a1A-AR is under the control of
E hormones. This special function of the a1A-AR may offer
a new pharmacologic possibility with which to promote suc-
cessful implantation.
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